A New Pro-Prodrug Aminoacid-Based for Trans-Ferulic Acid and Silybin Intestinal Release
Source abstract
Abstract
The aim of this work was the preparation and characterization of a pro-prodrug able to simultaneously transport silybin, a drug possessing various pharmacological effects, and trans-ferulic acid, a known antioxidant. More specifically, l-phenylalanine-N-(4-hydroxy-3-methoxy-phenyl) prop-2-en-O-(2R,3R)-3,5,7-trihydroxy-2-((2R,3R)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-benzo-(1,4)-dioxin-6-yl)croman-4-one was synthesized by using the aminoacid l-phenylalanine (l-Phe) as carrier. Indeed, l-Phe is characterized by an intrinsic chemical reactivity due to the presence of an amino group, placed on the chiral center, and of a carboxylic group. The synthesis has been characterized first by adding silybin by means of carboxylic group and then, with the aim to confer antioxidant properties to this new carrier, by linking trans-ferulic acid to l-Phe via amino group. The so obtained derivative was then characterized by FT-IR, and 1H-NMR spectroscopies. Furthermore, its ability to inhibit lipid peroxidation induced by tert-butyl hydroperoxide in rat liver microsomes, was evaluated. The 1,1-diphenyl-2-picrylhydrazyl radical-scavenging effect, was also assessed. The release of silybin and trans-ferulic acid was determined in simulated gastric and intestinal fluids over the time. The results showed that the covalent bond between both (i) silybin; or (ii) trans-ferulic acid and the amino acid was degraded by enzymatic reactions. In addition, the pro-prodrug, showed strong antioxidant and scavenger activities. Due to these properties, this new pro-prodrug could be applied for the treatment of intestinal pathologies and it might improve the therapeutic potential of silybin which is strongly limited by its low solubility.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Silymarin and Mushroom Poisoning · Synthesis and bioactivity of alkaloids · Botanical Research and Chemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmacy and Health and Nutrition Sciences, University of Calabria, 87036 Arcavacata di Rende Cosenza, Italy
References (36)
Show source-provided references
1. Analysis of the active components of silymarin10.1016/S0021-9673(02)01971-4 ↗
2. Effects of silymarin, a natural hepatoprotector, in periparturient dairy cows10.3168/jds.S0022-0302(04)70044-2 ↗
3. Silybin is a direct antifibrogenic and antiinflammatory agent: Cellular and molecular mechanisms10.1016/j.dld.2008.07.154 ↗
4. Pharmacology of silymarin10.2165/00044011-200222010-00007 ↗
5. The use of silymarin in the treatment of liver diseases10.2165/00003495-200161140-00003 ↗
6. Prostate cancer prevention by silibinin10.2174/1568009043481605 ↗
7. Antiangiogenic effect of silymarin on colon cancer LoVo cell line10.1016/S0022-4804(03)00229-4 ↗
8. Silybin-betacyclodextrin in the treatment of patients with diabetes mellitus and alcoholic liver disease. Efficacy study of a new preparation of an anti-oxidant agent
9. Cardioprotective activity of silymarin in ischemia-reperfusion-induced myocardial infarction in albino rats
10. Application of silymarin in human and animal medicine
11. In vitro antioxidant activity of silymarin10.1080/14756360802188081 ↗
12. Analysis of silibinin in rat plasma and bile for hepatobiliary excretion and oral bioavailability application10.1016/j.jpba.2007.06.026 ↗
13. An NMR and DSC study of the interaction of phospholipids vesicles with some anti-inflammatory agents10.1016/0021-9797(90)90119-9 ↗
14. Comparative bioavailability of silipide, a new flavanolignan complex, in rats10.1007/BF03189986 ↗
15. The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats10.1016/j.ijpharm.2005.10.001 ↗
16. Optimized preparation of silymarin dripping pills by a central composite design-response surface method
17. Enhanced bioavailability of silymarin by selfmicroemulsifying drug delivery system10.1016/j.ejpb.2005.12.005 ↗
18. Evaluation of hybrid liposomes encapsulated silymarin regarding physical stability and in vivo performance10.1016/j.ijpharm.2006.04.023 ↗
19. Preparation and evaluation of galactosylated vesicular carrier for hepatic targeting of silibinin10.3109/03639040903325560 ↗
20. The utility of cyclodextrins for enhancing oral bioavailability10.1016/j.jconrel.2007.07.018 ↗
21. Biodegradable pH-responsive alginate-poly (lactic-coglycolic acid) nano/micro hydrogel matrices for oral delivery of silymarin10.1016/j.carbpol.2010.09.055 ↗
22. Water soluble poly (ethylene glycol) prodrug of silybin: Design, synthesis, and characterization10.1002/app.27450 ↗
23. l-lysine pro-prodrug containing trans-ferulic acid for 5-amino salicylic acid colon delivery: Synthesis, characterization and in vitro antioxidant activity evaluation10.1248/cpb.58.103 ↗
24. Synthesis of pro-prodrugs l-lysine based for 5-aminosalicylic acid and 6-mercaptopurine colon specific release10.1016/j.ijpharm.2011.09.001 ↗
25. Colonic drug targeting10.3109/10611869808997888 ↗
26. Highly efficient stereoconservative amidation and deamidation of l-aminoacids10.1021/ol048771l ↗
27. Dicyclohexylcarbodiimmide assisted synthesis of aliphatic polyesters at room temperature10.1081/MA-100101114 ↗
28. Design and synthesis of cellulose derivatives with antioxidant activity10.1002/mabi.200700110 ↗
29. (2004). The United States Pharmacopeia, U.S. Pharmacopeial Convention. [27th ed.].
30. Superoxide dismutase depletion and lipid peroxidation in rat liver microsomal membranes: Correlation with liver carcinogenesis10.1016/0304-4165(88)90114-6 ↗
31. Measurement of malonaldehyde by high performance liquid chromatography with fluorescence detection10.1007/BF02535752 ↗
32. Antioxidant activity of ferulic acid β-glucuronide in the LDL oxidation system10.1271/bbb.61.1942 ↗
33. High molecular weight plant Polyphenolics (Tannins) as biological antioxidants10.1021/jf970975b ↗
34. Antioxidative phenolic compounds from Sage (Salvia officinalis)10.1021/jf980614b ↗
35. Use of a free radical method to evaluate antioxidant activity10.1016/S0023-6438(95)80008-5 ↗
36. Design, synthesis, hydrolysis kinetics and phamacodynamic profiles of histidine and alanine conjugates of aceclofenac10.2478/v10007-010-0003-1 ↗